Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic Stem Cell Transplantation, Allogeneic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT06613035
What this trial is testing

Twice-per-weekSelinexor, 2 Days Melphalan

Who this might be right for
Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China 126
Post-approval studies (Phase 4)UnknownNCT03190733
What this trial is testing

A Optimal Anti-Thymoglobuline (ATG) Dose Decrease cGVHD But Not Increase Leukemia Relapse for Haplo-HSCT

Who this might be right for
Chronic Graft-versus-host-diseaseLeukemia Relapse
Zhujiang Hospital 192
Large-scale testing (Phase 3)Ended earlyNCT00568633
What this trial is testing

Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML

Who this might be right for
Leukemia, MyeloidLeukemiaAcute Myeloid Leukemia (AML)
Stanford University 58
Early research (Phase 1)Not Yet RecruitingNCT07254793
What this trial is testing

Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT

Who this might be right for
Acute Lymphoid LeukemiaAcute Myeloid LeukemiaAcute Undifferentiated Leukemia (AUL)+3 more
University of Arizona 94
Large-scale testing (Phase 3)UnknownNCT00883714
What this trial is testing

Exercise During the Allogeneic Stem Cell Transplantation

Who this might be right for
FatigueAllogeneic Stem Cell Transplantation
Charite University, Berlin, Germany 60
Large-scale testing (Phase 3)Ended earlyNCT00117702
What this trial is testing

Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation With Tacrolimus and Everolimus

Who this might be right for
Graft vs Host Disease
Technische Universität Dresden 24
Testing effectiveness (Phase 2)Study completedNCT00847639
What this trial is testing

Safety Study of Lenalidomide Maintenance Therapy Post Allogeneic HCT for High-risk Multiple Myeloma

Who this might be right for
Multiple Myeloma
Center for International Blood and Marrow Transplant Research 30
Large-scale testing (Phase 3)Study completedNCT01020175
What this trial is testing

Peripheral Blood (PB) Versus Bone Marrow (BM) in Allogeneic Stem Cell Transplantation

Who this might be right for
Acute LeukemiaChronic Myelogenous LeukemiaMyelodysplastic Syndrome
European Society for Blood and Marrow Transplantation 350
Early research (Phase 1)UnknownNCT02780895
What this trial is testing

Parkinsonian Brain Repair Using Human Stem Cells

Who this might be right for
Idiopathic Parkinson Disease
Celavie Bioscences, LLC 8
Testing effectiveness (Phase 2)Study completedNCT02806375
What this trial is testing

PTCy and Ruxolitinib GVHD Prophylaxis in Myelofibrosis

Who this might be right for
Primary MyelofibrosisMyeloproliferative Disorders
St. Petersburg State Pavlov Medical University 20
Testing effectiveness (Phase 2)Study completedNCT01386619
What this trial is testing

NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic Syndromes+3 more
University Hospital, Basel, Switzerland 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04451200
What this trial is testing

Sequential and Personalized PK-guided Busulfan Administration in the Frame of the Conditiong Regimen for Allo-HSCT in Patients With Malignant Hemopathies Ineligible for the Standard Myeloablative Conditioning

Who this might be right for
Acute LeukemiaMielodysplasic SyndromeMyeloproliferative Neoplasm
Institut Paoli-Calmettes 82
Not applicableNot Yet RecruitingNCT07710781
What this trial is testing

Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies

Who this might be right for
Hematologic MalignancyAcute LeukemiaAcute Lymphoblastic Leukemia+9 more
Ossium Health, Inc. 300
Testing effectiveness (Phase 2)Study completedNCT02638467
What this trial is testing

Allogeneic Stem Cell Transplantation in Chronic Myeloid Leukemia Failing TKIs Therapy

Who this might be right for
LeukemiaMyelogenousChronic+1 more
University of Milano Bicocca 2
Not applicableEnded earlyNCT02360111
What this trial is testing

GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant

Who this might be right for
LeukemiaMyelodysplastic SyndromeNon-Hodgkin's Lymphoma
Memorial Sloan Kettering Cancer Center 3
Large-scale testing (Phase 3)Ended earlyNCT04326764
What this trial is testing

Panobinostat Maintenance After HSCT fo High-risk AML and MDS

Who this might be right for
Acute Myeloid Leukaemia (AML)Myelodysplastic Syndromes (MDS)
Goethe University 52
Not applicableStudy completedNCT05968963
What this trial is testing

Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Stem Cell TransplantationMyelodysplastic SyndromesLeukemia, Myeloid, Acute+2 more
University of Miami 61
Testing effectiveness (Phase 2)Study completedNCT00146614
What this trial is testing

Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell Transplantation

Who this might be right for
Graft Versus Host DiseaseHematologic Malignancies
Dana-Farber Cancer Institute 105
Not applicableStudy completedNCT06000306
What this trial is testing

MRD Monitoring by Digital Droplet PCR in the Early Period After Allo-HSCT to Predict Patients at High Risk of Relapse

Who this might be right for
Measurable Residual Disease
Zhejiang University 192
Testing effectiveness (Phase 2)Ended earlyNCT02648932
What this trial is testing

The Rapid Study: Randomized Phase II Study To Expedite Allogeneic Transplant With Immediate Haploidentical Plus Unrelated Cord Donor Search Versus Matched Unrelated Donor Search For AML And High-Risk MDS Patients

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)
University of Chicago 9
Next Page